DR. JEREMY ABRAMSON
Dr. Jeremy Abramson is a Director of the Lymphoma Program and the Jon and Jo Ann Hagler Chair in Lymphoma at the Massachusetts General Hospital Cancer Center, Boston, Massachusttes, USA.
He is also an Associate Professor of Medicine at Harvard Medical School.
PROF. RANJANA ADVANI, MD
Prof. Ranjana Advani is a Professor of Medicine at Stanford University, California, USA, specializing in the field of lymphoma. She holds an endowed chair (Saul Rosenberg Professor) and oversees all aspects of treatment of the vast majority of adult lymphoma patients.
DR. N. NORA BENNANI
Dr. Nora Bennani is a faculty and an Assistant Professor of Medicine at the Mayo Clinic, College of Medicine and Science, Rochester, Minnesota, USA.
PROF. ANDREW DAVIES
Prof. Andrew Davies is Professor of Hematological Oncology in the Cancer Sciences Unit in the Faculty of Medicine, University Hospital Southampton, UK. He is Director of the Cancer Research UK/National Institute of Health Southampton Experimental Cancer Medicine Centre.
PROF. KIERON DUNLEAVY
Prof. Kieron Dunleavy is Director of Hematology and leader of the lymphoma program at Lombardi Comprehensive Cancer Center, Georgetown University, Washington DC, USA. He is a Professor of Medicine at Georgetown University.
PROF. FRANCINE FOSS
Prof. Francine Foss is a Professor of Medicine in the Section of Medical Oncology at the Yale Cancer Center, is an internationally recognized clinician and clinical researcher with expertise in adult lymphomas and in stem cell allotransplantation.
PROF. MARTIN HUTCHINGS
Prof. Martin Hutchings is a Hemato-Oncologist and a Senior Consultant from the Department of Hematology, Rigshospitalet, Copenhagen University Hospital and a Professor of Hematology at the University of Copenhagen, Denmark.
PROF. WON KIM
Prof. Won-Seog Kim is a Professor of the Division of Hematology-Oncology at Samsung Medical Center, South Korea and Head of the Malignant Lymphoma Center. He is working as a Chairman of the lymphoma working party of the Korean Society of Hematology and consortium for improved survival of lymphoma (CISL). He is also one of the founding members of the Asian Lymphoma study group (ALSG).
He is now co-chairing of T-cell lymphoma forum.
PROF. DAVID LEWIS
Prof. David Lewis is a Consultant Hematologist currently affiliated with Plymouth University Hospital NHS, England, UK. With a strong focus on lymphoma, he has established himself as a leading expert in the field. Dr. Lewis holds the position of Lymphoma Multidisciplinary Team (MDT) Lead and oversees the operations of the specialist mantle cell lymphoma clinic and clinical trials clinic at Derriford, which has gained recognition as one of the top recruiters for lymphoma trials in the United Kingdom.
PROF. OWEN O’CONNOR
Prof. Owen O’Connor is an internationally recognized authority in lymphoma, drug discovery and development and translational research. He holds the American Cancer Society Research Professorship, the most distinguished award made by the American Cancer Society. He is a Professor of Medicine and Microbiology, Cancer Biology and Immunology, at the University of Virginia Cancer Center.
DR. ANTONIO SALAR
Dr. Antonio Salar is specialist in Hematology. He is the Section Head of the Department of Clinical Hematology at the Hospital del Mar, Barcelona and Associate Professor of Hematology in the Universidad Autónoma de Barcelona, Spain. Dr. Salar’s main topic of interest is clinical and translational research in indolent lymphomas, and in particular MALT lymphomas. He has contributed with approximately 80 publications in national and international medical journals.